Umbilical cord blood transplantation: current status and future directions

Umbilical cord blood is an appealing alternative source of hematopoietic stem cells for children and adults undergoing transplantation for a wide variety of diseases. Shorter time to transplant, which is particularly relevant for patients requiring urgent transplantation, and tolerance of 1–2 human leukocyte antigen mismatches, which increases the chance of finding a suitable donor, are evident advantages over bone marrow transplantation from unrelated donors. The speed of engraftment is slower after cord blood transplantation, but this is counterbalanced by a lower incidence of severe graft-versus-host disease. Cell dose and human leukocyte antigen are major factors influencing the outcomes of umbilical cord blood transplantation. Unrelated donor cord blood is considered an acceptable alternative to bone marrow for pediatric transplantation, and recent data in adults point the same way. This review describes the current status of cord blood transplantation and discusses developing research strategies aimed at optimizing this kind of transplantation.

[1]  J. Zaia.  Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Sanz,et al.  Unrelated donor umbilical cord blood transplantation in adults , 2002, Leukemia.

[3]  P. Wernet,et al.  Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. , 2002, Blood.

[4]  K. Yamanishi,et al.  High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. , 2002, Blood.

[5]  A. Zander,et al.  Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. A potential source of megakaryocytes for transplantation. , 2002, Experimental hematology.

[6]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[7]  S. Asano,et al.  A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission , 2002, British journal of haematology.

[8]  Zhigang Gao,et al.  Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. , 2002, Experimental hematology.

[9]  Chan Zeng,et al.  Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  E. Shpall,et al.  Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. , 2002, Experimental hematology.

[11]  Chi-kong Li,et al.  Platelet‐derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long‐term culture‐initiating cells, non‐obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells , 2002, British journal of haematology.

[12]  P. Chan,et al.  Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children , 2002, Bone Marrow Transplantation.

[13]  D. Rizzieri,et al.  Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  Todd E DeFor,et al.  Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  J. Kurtzberg,et al.  Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. , 2002, Experimental hematology.

[16]  D. Douek,et al.  A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. , 2002, Blood.

[17]  K. Ohnuma,et al.  Cord Blood Transplantation from HLA-mismatched Unrelated Donors , 2002, Leukemia & lymphoma.

[18]  A. Shibuya,et al.  Successful Reduced-intensity Stem Cell Transplant from One-locus HLA-mismatched Unrelated Cord Blood after Rejection of Unrelated Bone Marrow in an Infant with Myelogenous Leukemia , 2002, Hematology.

[19]  J. Hows,et al.  In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells , 2002, British journal of haematology.

[20]  N. Schmitz,et al.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.

[21]  M. Lima.  Umbilical Cord Blood Transplantation in Adults , 2001 .

[22]  J Wagner,et al.  Current status of cord blood banking and transplantation in the United States and Europe. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  A. Verdeguer,et al.  Herpesvirus-6 Encephalitis Complicated by Wernicke–Korsakoff Syndrome in a Pediatric Recipient of Unrelated Cord Blood Transplantation , 2001, Journal of pediatric hematology/oncology.

[24]  D. Rizzieri,et al.  Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. , 2001, Blood.

[25]  D. Williams,et al.  Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. , 2001, Human gene therapy.

[26]  P. Bolufer,et al.  Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. , 2001, Blood.

[27]  F. Prósper,et al.  Ex vivo expansion of umbilical cord blood (UCB) CD34+ cells alters the expression and function of α4β1 and α5β1 integrins , 2001 .

[28]  S. Asano,et al.  Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome‐related secondary acute myeloid leukaemia , 2001, British journal of haematology.

[29]  B. Haynes,et al.  T-Cell recovery in adults and children following umbilical cord blood transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[30]  J. García,et al.  Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms , 2001, Bone Marrow Transplantation.

[31]  A. Pettitt,et al.  p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. , 2001, Blood.

[32]  R. Porcher,et al.  Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children – a Eurocord analysis , 2001, British journal of haematology.

[33]  J. Wagner,et al.  Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[34]  R. Pasquini,et al.  Unrelated cord blood transplantion in a Fanconi anemia patient using fludarabine-based conditioning , 2001, Bone Marrow Transplantation.

[35]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[36]  J. Wagner,et al.  Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. , 2001, The New England journal of medicine.

[37]  S. Chevret,et al.  Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. , 2001, Reviews in clinical and experimental hematology.

[38]  C. Verfaillie,et al.  Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. , 2001, Blood.

[39]  J. Wagner,et al.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. , 2001, Blood.

[40]  A. Zander,et al.  Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. , 2001, Blood.

[41]  A. Tosti,et al.  Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. , 2001, Blood.

[42]  C. Chui,et al.  Successful engraftment in two adult patients with severe aplastic anemia using nonmyeloablative conditioning followed by unrelated HLA-mismatched cord blood transplantation. , 2001, Journal of hematotherapy & stem cell research.

[43]  P. Bolufer,et al.  Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution , 2001, Bone Marrow Transplantation.

[44]  F. Locatelli,et al.  Analysis of immune reconstitution in children undergoing cord blood transplantation. , 2001, Experimental hematology.

[45]  D. Wall,et al.  UNRELATED CORD BLOOD TRANSPLANT EXPERIENCE BY THE PEDIATRIC BLOOD AND MARROW TRANSPLANT CONSORTIUM , 2001, Pediatric hematology and oncology.

[46]  A. Nademanee,et al.  Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program , 2000 .

[47]  P. Rubinstein,et al.  Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. , 2000, Bailliere's best practice & research. Clinical haematology.

[48]  E. Gluckman.  Current status of umbilical cord blood hematopoietic stem cell transplantation. , 2000, Experimental hematology.

[49]  J. Adamson,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS , 2022 .

[50]  J. Klein,et al.  Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. , 2000, The New England journal of medicine.

[51]  A. Nademanee,et al.  Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. , 2000, Blood.

[52]  ohn,et al.  The GRAFT-VERSUS-HOST DISEASE IN CHILDREN WHO HAVE RECEIVED A CORD-BLOOD OR BONE MARROW TRANSPLANT FROM AN HLA-IDENTICAL SIBLING , 2000 .

[53]  A. Nademanee,et al.  Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. , 2000, Blood.

[54]  J. Segovia,et al.  Delayed Engraftment of Nonobese Diabetic/Severe Combined Immunodeficient Mice Transplanted With Ex Vivo–Expanded Human CD34+ Cord Blood Cells , 1999 .

[55]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[56]  C Anasetti,et al.  Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.

[57]  J. Wagner,et al.  Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. , 1997, Blood.

[58]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[59]  R Storb,et al.  Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. , 1997, Blood.

[60]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.

[61]  J. Wagner,et al.  Allogeneic umbilical cord blood transplantation. , 1997, Cancer treatment and research.

[62]  V. Barbu,et al.  Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. , 1996, The New England journal of medicine.

[63]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[64]  J. Kurtzberg,et al.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.